Wednesday, March 8, 12:00pm - 1:00pm (EST)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
Join our webinar on Wednesday, March 8th to learn more about the landmark decision made by Australia's Therapeutic Goods Agency (“TGA”) and how that will affect the psychedelic marketplace.
Speakers from PharmAla Biotech will discuss the TGA's regulatory change that will make Australia the first country in the world to allow qualified psychiatrists to prescribe MDMA and Psilocybin and how PharmAla plans to responsibly supply our customers with high-quality EU-GMP API and drug products.
Bring your questions, and we'll see you there!
You're going to "Changes Announced By The TGA & What It Means For Psychedelics".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
You're interested in "Changes Announced By The TGA & What It Means For Psychedelics".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
Thank you!
Your changes have been saved. Thanks for keeping us updated.
https://us06web.zoom.us/j/85869930070
PharmAla Biotech